• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发一种基于可解释机器学习和雾计算的视觉评分量表,用于预测痴呆症进展。

Developing an explainable machine learning and fog computing-based visual rating scale for the prediction of dementia progression.

作者信息

Ali Zainab H, Hassan Esraa, Elgamal Shimaa, El-Rashidy Nora

机构信息

Department of Embedded Network Systems and Technology, Faculty of Artificial Intelligence, Kafrelsheikh University, El-Geish St, Kafrelsheikh, 33516, Egypt.

Department of Electronics and Computer Engineering, School of Engineering and Applied Sciences, Nile University, Giza, Egypt.

出版信息

Sci Rep. 2025 Jul 16;15(1):25872. doi: 10.1038/s41598-025-06310-4.

DOI:10.1038/s41598-025-06310-4
PMID:40670451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12267627/
Abstract

Recently, dementia research has primarily concentrated on using Magnetic Resonance Imaging (MRI) to develop learning models in processing and analyzing brain data. However, these models often cannot provide early detection of affected brain regions. Alternatively, mental test scores such as the Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) offer valuable insights into the likelihood of dementia and cognitive impairments. The main objective of this study is to introduce an innovative and dependable context-aware health monitoring system based on fog computing to measure mental impairment in the elderly population. The framework provides screening tests utilizing MMSE and MoCA to achieve accurate and real-time monitoring of cognitive function, allowing for early detection and treatment of mental disorders. To assess the effectiveness of our screening test, we evaluated a dataset comprising 450 subjects with Mild Cognitive Impairment (MCI) from Kaferelshikh University. The aggregated dataset is categorized into three classes: (1) 150 patients with MCI, (2) 150 subjects with subcortical diseases, Parkinson's Disease (PD), and (3) 150 subjects with cortical diseases, Alzheimer's Disease (AD). To accurately determine health risks, we employ an ensemble AdaBoost model, providing superior performance in accuracy, precision, recall, F-score, and Area Under the Curve (AUC). To validate the effectiveness of our Machine Learning (ML) model on unseen data, we evaluate an additional 18 subjects using the proposed scoring test, with six subjects from each class. The results indicate that our proposed ML model achieves an impressive accuracy of 0.93, outperforming the MoCA score (0.90) and MMSE score (0.83). Through our research, we demonstrate the potential of our context-aware fog computing approach in significantly enhancing early diagnosis of dementia, leveraging mental test scores as valuable indicators.

摘要

最近,痴呆症研究主要集中在利用磁共振成像(MRI)来开发处理和分析大脑数据的学习模型。然而,这些模型往往无法对受影响的脑区进行早期检测。相比之下,诸如简易精神状态检查表(MMSE)和蒙特利尔认知评估量表(MoCA)等心理测试分数能为痴呆症和认知障碍的可能性提供有价值的见解。本研究的主要目标是引入一种基于雾计算的创新且可靠的情境感知健康监测系统,以测量老年人群的精神损伤。该框架利用MMSE和MoCA提供筛查测试,以实现对认知功能的准确实时监测,从而能够早期发现和治疗精神障碍。为了评估我们筛查测试的有效性,我们评估了来自卡费雷尔希赫大学的一个包含450名轻度认知障碍(MCI)受试者的数据集。汇总后的数据集分为三类:(1)150名MCI患者,(2)150名患有皮质下疾病、帕金森病(PD)的受试者,以及(3)150名患有皮质疾病、阿尔茨海默病(AD)的受试者。为了准确确定健康风险,我们采用了集成AdaBoost模型,该模型在准确率、精确率、召回率、F值和曲线下面积(AUC)方面表现优异。为了验证我们的机器学习(ML)模型在未见数据上的有效性,我们使用所提出的评分测试对另外18名受试者进行了评估,每个类别有6名受试者。结果表明,我们提出的ML模型实现了令人印象深刻的0.93的准确率,优于MoCA分数(0.90)和MMSE分数(0.83)。通过我们的研究,我们证明了情境感知雾计算方法在利用心理测试分数作为有价值指标显著增强痴呆症早期诊断方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/3e5bfbcd1414/41598_2025_6310_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/b77d35b358b7/41598_2025_6310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/3eea63d820e9/41598_2025_6310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/dfe898d938d7/41598_2025_6310_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/dfef65ac1a01/41598_2025_6310_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/355cc9f8781c/41598_2025_6310_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/2911029be68c/41598_2025_6310_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/eb382eea2d8b/41598_2025_6310_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/79e039a33938/41598_2025_6310_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/a92f48255291/41598_2025_6310_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/bd8e9452ba78/41598_2025_6310_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/f98d5f20a61e/41598_2025_6310_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/cb55e1e797c1/41598_2025_6310_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/fea9bcc6b5c5/41598_2025_6310_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/3e5bfbcd1414/41598_2025_6310_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/b77d35b358b7/41598_2025_6310_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/3eea63d820e9/41598_2025_6310_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/dfe898d938d7/41598_2025_6310_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/dfef65ac1a01/41598_2025_6310_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/355cc9f8781c/41598_2025_6310_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/2911029be68c/41598_2025_6310_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/eb382eea2d8b/41598_2025_6310_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/79e039a33938/41598_2025_6310_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/a92f48255291/41598_2025_6310_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/bd8e9452ba78/41598_2025_6310_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/f98d5f20a61e/41598_2025_6310_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/cb55e1e797c1/41598_2025_6310_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/fea9bcc6b5c5/41598_2025_6310_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1ed/12267627/3e5bfbcd1414/41598_2025_6310_Fig13_HTML.jpg

相似文献

1
Developing an explainable machine learning and fog computing-based visual rating scale for the prediction of dementia progression.开发一种基于可解释机器学习和雾计算的视觉评分量表,用于预测痴呆症进展。
Sci Rep. 2025 Jul 16;15(1):25872. doi: 10.1038/s41598-025-06310-4.
2
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
3
Predicting cognitive decline: Deep-learning reveals subtle brain changes in pre-MCI stage.预测认知衰退:深度学习揭示轻度认知障碍前阶段大脑的细微变化。
J Prev Alzheimers Dis. 2025 May;12(5):100079. doi: 10.1016/j.tjpad.2025.100079. Epub 2025 Feb 6.
4
One-year practice effects predict long-term cognitive outcomes in Parkinson's disease.一年的练习效果可预测帕金森病的长期认知结果。
J Parkinsons Dis. 2025 Apr 29:1877718X251339585. doi: 10.1177/1877718X251339585.
5
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
6
Multi-domain interventions for the prevention of dementia and cognitive decline.多领域干预措施预防痴呆和认知能力下降。
Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013572. doi: 10.1002/14651858.CD013572.pub2.
7
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).¹⁸F - 氟代脱氧葡萄糖正电子发射断层显像(¹⁸F - FDG PET)用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2.
8
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
9
18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代硼吡咯进行18F正电子发射断层显像以早期诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012216. doi: 10.1002/14651858.CD012216.pub2.
10
Dementia Overdiagnosis in Younger, Higher Educated Individuals Based on MMSE Alone: Analysis Using Deep Learning Technology.仅基于简易精神状态检查表(MMSE)对年轻、高学历个体的痴呆症过度诊断:使用深度学习技术的分析
J Korean Med Sci. 2025 Mar 10;40(9):e20. doi: 10.3346/jkms.2025.40.e20.

本文引用的文献

1
Generalizable deep learning model for early Alzheimer's disease detection from structural MRIs.基于结构 MRI 的泛化深度学习模型用于早期阿尔茨海默病检测。
Sci Rep. 2022 Oct 17;12(1):17106. doi: 10.1038/s41598-022-20674-x.
2
A deep learning model for detection of Alzheimer's disease based on retinal photographs: a retrospective, multicentre case-control study.基于视网膜照片的阿尔茨海默病检测深度学习模型:一项回顾性、多中心病例对照研究。
Lancet Digit Health. 2022 Nov;4(11):e806-e815. doi: 10.1016/S2589-7500(22)00169-8. Epub 2022 Sep 30.
3
Perspectives and challenges in patient stratification in Alzheimer's disease.
阿尔茨海默病患者分层的观点与挑战。
Alzheimers Res Ther. 2022 Aug 13;14(1):112. doi: 10.1186/s13195-022-01055-y.
4
Early diagnosis of Alzheimer's disease using machine learning: a multi-diagnostic, generalizable approach.利用机器学习进行阿尔茨海默病的早期诊断:一种多诊断、可推广的方法。
Alzheimers Res Ther. 2022 Aug 3;14(1):107. doi: 10.1186/s13195-022-01047-y.
5
Identification and validation of Alzheimer's disease-related metabolic brain pattern in biomarker confirmed Alzheimer's dementia patients.鉴定和验证生物标志物确诊的阿尔茨海默病患者中与阿尔茨海默病相关的代谢性脑模式。
Sci Rep. 2022 Jul 11;12(1):11752. doi: 10.1038/s41598-022-15667-9.
6
Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.帕金森病患者的抑郁:对其神经生物学的现有理解及其对治疗的影响。
Drugs Aging. 2022 Jun;39(6):417-439. doi: 10.1007/s40266-022-00942-1. Epub 2022 Jun 16.
7
The neuropsychiatry of Parkinson's disease: advances and challenges.帕金森病的神经精神医学:进展与挑战。
Lancet Neurol. 2022 Jan;21(1):89-102. doi: 10.1016/S1474-4422(21)00330-6.
8
MRI Deep Learning-Based Solution for Alzheimer's Disease Prediction.基于MRI深度学习的阿尔茨海默病预测解决方案。
J Pers Med. 2021 Sep 9;11(9):902. doi: 10.3390/jpm11090902.
9
Challenges in the diagnosis of Parkinson's disease.帕金森病诊断中的挑战。
Lancet Neurol. 2021 May;20(5):385-397. doi: 10.1016/S1474-4422(21)00030-2.
10
Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease.遗传性阿尔茨海默病患者脑微出血的纵向累积。
Neurology. 2021 Mar 23;96(12):e1632-e1645. doi: 10.1212/WNL.0000000000011542. Epub 2021 Jan 25.